← All tickers

Is RVMD Worth Buying in 2026?

Revolution Medicines, Inc. Common Stock

STOCK BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Updated 2026-08-23

Here’s whether Revolution Medicines, Inc. Common Stock (RVMD) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+6.34% over 10 days); strong 1-year return of +474.2%; 3-month momentum positive (+38.2%). Concerns: RSI 77 — overbought, elevated pullback risk. Currently 4.9% off its 52-week high. Score: +5/7.

Ready to act on this? 📈 Trade on Webull

RVMD is in a confirmed uptrend, trading above both its 50-day ($187.00) and 200-day ($126.66) moving averages. With an RSI of 77.0, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +474.2% compares to +20.5% for SPY (beat the market by 453.7%).

$10,000 invested 1 year ago → $57,418 today
vs. S&P 500 (SPY) — same period beat market by 453.7%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 200-day MA ($126.66)
✓Above 50-day MA ($187.00)
!RSI(14) neutral zone (30–70) — currently 77.0
✓Positive return (+474.2%)
✓Within 10% of period high (−4.9%)
Period Range $209.46
$35.42 $220.34
RSI (14) 77.0
0 · OversoldOverbought · 100

Key Metrics

Price$209.46
Period Return+474.2%
Period High$220.34
Period Low$35.42
Drawdown−4.9%
MA-50$187.00
MA-200$126.66
RSI (14)77.0
Avg Volume (30d)1.8M
vs. SPYbeat by 453.7%
Return Rank#11 of 999

Trade RVMD

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers